8-K: Profusa Announces 1-for-25 Reverse Stock Split

Profusa, Inc. has filed a Form 8-K announcing a 1-for-25 reverse stock split of its common stock, effective July 7, 2026, to reduce outstanding shares and adjust equity awards.

Summary

• Profusa, Inc. has officially implemented a 1-for-25 reverse stock split of its common stock.
• This action was approved by stockholders at the annual meeting on June 23, 2026, and authorized by the Board of Directors.
• The reverse stock split will become effective at 12:01 a.m. Eastern Time on July 7, 2026.
• Following the split, the company's common stock will trade on The Nasdaq Capital Market under the existing ticker symbol PFSA, but with a new CUSIP number.
• The split will reduce the number of outstanding shares from approximately 13.2 million to about 530,000, while the authorized shares remain at 601 million.
• Adjustments will be made to stock options, RSUs, PSUs, and warrants to reflect the split ratio, including proportional increases in exercise prices for options and warrants.
• Fractional shares resulting from the split will be settled in cash, calculated based on the closing price on the effective date.
• The company also provided historical financial data showing net losses and net loss per share for the years ended December 31, 2025 and 2024, and the three months ended March 31, 2026 and 2025, both pre-split and post-split.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as having a neutral to slightly negative sentiment due to the nature of a reverse stock split, which often signals underlying stock price weakness, despite the operational adjustments it entails.

Positives

• The reverse stock split is intended to reduce the number of outstanding shares, which can sometimes improve the stock's market perception and trading liquidity.
• The company is maintaining its existing ticker symbol (PFSA) on The Nasdaq Capital Market, minimizing disruption for investors.
• Adjustments to equity awards and outstanding warrants are being made proportionally, aiming to maintain fairness for all security holders.

Negatives

• The reverse stock split significantly increases the net loss per share on a post-split basis, reflecting the reduced number of shares outstanding against the same net loss.
• For the year ended December 31, 2025, the net loss per share increased from $(107.01) pre-split to $(2,675.35) post-split.
• For the three months ended March 31, 2026, the net loss per share increased from $(2.05) pre-split to $(51.18) post-split.
• Fractional shares will be paid out in cash, which could result in a small cash payout for shareholders holding a number of shares not divisible by 25.

Risks

• The reverse stock split is often implemented to meet minimum bid price requirements for stock exchange listing, suggesting potential prior price weakness.
• The company has experienced significant net losses in its reported periods, indicating ongoing financial challenges.
• Forward-looking statements are subject to risks and uncertainties, including those described in other SEC filings, which could cause actual results to differ materially.

Future Outlook

The filing does not contain specific forward-looking financial guidance. However, it notes that forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from projections.

Management Comments

• The company's Chief Executive Officer approved the one-for-twenty-five (1:25) reverse stock split ratio and the filing of the amendment to effect the split.
• Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.

Industry Context

StockSavvy.ai notes that reverse stock splits are often employed by companies, particularly in the biotechnology and digital health sectors, to increase their stock price per share, potentially to meet exchange listing requirements or improve investor perception. This move by Profusa, a commercial-stage digital health company, aligns with this trend.

Corporate Governance

Stakeholder Impact

• Shareholders will see their number of shares reduced by a factor of 25, with fractional shares being cashed out.
• Holders of stock options, RSUs, PSUs, and warrants will have their awards adjusted proportionally, potentially increasing exercise prices for options and warrants.
• The reduction in outstanding shares may affect per-share metrics, making them appear more volatile on a historical basis.

Next Steps

• The reverse stock split will become effective at 12:01 a.m. Eastern Time on July 7, 2026.
• The company's common stock will commence trading on a post-split basis on The Nasdaq Capital Market on July 7, 2026.

Key Dates

Recommendation

The filing details a reverse stock split, a procedural change rather than a fundamental business update. While it may address listing requirements or market perception, it does not inherently alter the company's intrinsic value or future prospects. Investors should continue to monitor the company's core business performance and financial health.

Keywords

Profusa, Reverse Stock Split, Form 8-K, Common Stock, Nasdaq, Stockholder Meeting, Equity Awards, Financial Metrics, Digital Health